Stocktoria
BioScience Health Innovations, Inc. BHIC
OTC · stock · Services-Computer Processing & Data Preparation
BioScience Health Innovations, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $5.7M | $1.8M | $597,595 | $69,343 | $0 | $0 | $0 |
| Gross profit | $3.2M | $1.3M | $484,407 | $59,644 | — | — | — |
| R&D expense | $37,540 | $25,908 | $0 | — | — | — | — |
| SG&A expense | $2.2M | $1.1M | $706,257 | $151,319 | $91,921 | $25,610 | $7,682 |
| Operating income | $719,051 | $87,000 | -$251,500 | -$170,450 | -$91,921 | -$25,610 | -$7,682 |
| Interest expense | — | — | — | — | — | $450 | — |
| Income tax | $76,961 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | $642,090 | $87,000 | -$251,500 | -$170,450 | -$83,208 | -$25,610 | -$7,682 |
| EPS (diluted) | $0.06 | $0.01 | $-0.01 | — | — | — | — |
| Operating cash flow | $172,178 | $23,188 | -$307,842 | -$182,779 | -$85,782 | -$29,439 | -$7,682 |
| Cash & equivalents | $661,925 | $662,517 | $19,238 | $11,569 | — | $2,035 | $20,629 |
| Inventory | $336,348 | $58,319 | $37,702 | $12,278 | — | — | — |
| Total assets | $1.7M | $873,788 | $93,388 | $31,608 | $16,253 | $6,314 | $20,629 |
| Total liabilities | $229,851 | $38,548 | $100,148 | $48,791 | $1,860 | $19,106 | $7,811 |
| Shareholders' equity | $1.5M | $835,240 | -$6,760 | -$17,183 | $14,393 | -$12,792 | $12,818 |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue growth | +208.3% | +208.7% | +761.8% | — | — | — | — |
| Net income growth | +638.0% | — | — | — | — | — | — |
| EPS growth | +500.0% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.